110 related articles for article (PubMed ID: 681701)
1. [The treatment of benign pathological conditions of the breasts with progesterone and progestogens. The results according to the type of breast condition (260 case records) (author's transl)].
Mauvais-Jarvis P; Sterkers N; Kuttenn F; Beauvais J
J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3):477-84. PubMed ID: 681701
[TBL] [Abstract][Full Text] [Related]
2. Combined tamoxifen-lynestrenol treatment in benign breast disease.
Cupceancu B
Endocrinologie; 1985; 23(4):265-72. PubMed ID: 4089504
[TBL] [Abstract][Full Text] [Related]
3. [Current therapeutic data concerning mastodynia and benign mastopathies].
Mauvais-Jarvis P
Therapeutique; 1972 Nov; 48(9):575-8. PubMed ID: 4650527
[No Abstract] [Full Text] [Related]
4. [Biologic bases of the treatment of diffuse benign breast diseases].
Van Bogaert LJ
J Gynecol Obstet Biol Reprod (Paris); 1976 Jun; 5(4):567-75. PubMed ID: 783246
[TBL] [Abstract][Full Text] [Related]
5. Short-term tamoxifen treatment in benign breast diseases.
Cupceancu B
Endocrinologie; 1985; 23(3):169-77. PubMed ID: 4048817
[TBL] [Abstract][Full Text] [Related]
6. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Effects of sex steroids on proliferation in normal mammary tissue.
Söderqvist G
Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of diffuse dyshormonal hyperplasia of the breasts].
Sidorenko LN; Shal'neva TS
Vopr Onkol; 1973; 19(11):72-6. PubMed ID: 4785976
[No Abstract] [Full Text] [Related]
10. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
11. Role of progestins in the premenopausal climacteric.
Schindler AE
Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():35-40. PubMed ID: 10862267
[TBL] [Abstract][Full Text] [Related]
12. Oral contraception and breast pathology.
Ragni N; Boccardo E; Viglino S; Larosa E
Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles].
Kubista E; Müller G; Spona J
Rev Fr Gynecol Obstet; 1987 Apr; 82(4):221-7. PubMed ID: 3589362
[TBL] [Abstract][Full Text] [Related]
14. Benign breast disease.
Mauvais-Jarvis P; Kuttenn F
Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
[No Abstract] [Full Text] [Related]
15. [Results of treating mastodynias and mastopathies with percutaneous progesterone].
Mauvais-Jarvis P; Kuttenn F; Ohlgiesser C
Nouv Presse Med; 1974 Apr; 3(16):1027-8. PubMed ID: 4836479
[No Abstract] [Full Text] [Related]
16. Progestogen use in women approaching the menopause and breast cancer risk.
Campagnoli C; Ambroggio S; Lotano MR; Peris C
Maturitas; 2009 Apr; 62(4):338-42. PubMed ID: 19118958
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
[TBL] [Abstract][Full Text] [Related]
18. Benign breast disease and breast cancer risk: potential role for antiestrogens.
Schnitt SJ
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4419s-4422s; discussion 4411s-4412s. PubMed ID: 11916234
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of various progestogens on metabolic risk factors for breast cancer.
Campagnoli C; Abbà C; Ambroggio S; Lotano MR; Peris C
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():22-31. PubMed ID: 17943536
[TBL] [Abstract][Full Text] [Related]
20. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
Seeger H; Wallwiener D; Mueck AO
Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
